share_log

4: Statement of changes in beneficial ownership of securities-Director Allen Charles W

4: Statement of changes in beneficial ownership of securities-Director Allen Charles W

4:持股變動聲明-董事 Allen Charles W
美股sec公告 ·  05/21 20:20
Moomoo AI 已提取核心訊息
On May 16, 2024, Charles W. Allen, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of the company's common stock. The transaction was executed at a price of $0.223 per share. Following this acquisition, Allen's direct holdings in the company increased to a total of 14,000 shares. The transaction is categorized as an exercise or conversion of derivative security, and it reflects Allen's growing stake in the pharmaceutical company.
On May 16, 2024, Charles W. Allen, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of the company's common stock. The transaction was executed at a price of $0.223 per share. Following this acquisition, Allen's direct holdings in the company increased to a total of 14,000 shares. The transaction is categorized as an exercise or conversion of derivative security, and it reflects Allen's growing stake in the pharmaceutical company.
2024年5月16日,與60度製藥相關的查爾斯·艾倫完成了對該公司4,000股普通股的收購。該交易以每股0.223美元的價格執行。此次收購後,艾倫在該公司的直接持股量增加到總計14,000股。該交易被歸類爲衍生證券的行使或轉換,它反映了艾倫在這家制藥公司的股份不斷增加。
2024年5月16日,與60度製藥相關的查爾斯·艾倫完成了對該公司4,000股普通股的收購。該交易以每股0.223美元的價格執行。此次收購後,艾倫在該公司的直接持股量增加到總計14,000股。該交易被歸類爲衍生證券的行使或轉換,它反映了艾倫在這家制藥公司的股份不斷增加。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息